Publication by Species:
Comparison of the efficacy and adverse effects of sustained-release Buprenorphine hydrochloride following subcutaneous administration and Buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy.
Catbagan DL;Quimby JM; Mama KR; Rychel JK; Mich PM
AJVR, Vol 72, No. 4, April 2011, 461-466
Comparison Of Sustained Release Buprenorphine and Transmucosal Buprenorphine In Cats
Clinical Research Bulletin, SR Veterinary Technologies,Jauary 2011
RATS / MICE
Buprenorphine SR: Dose Comparison of pK Data in Mice
Clinical Research, SR Veterinary Technologies, 2013.
Healey et al., Evaluation of an improved sustained-release buprenorphine formulation for use in mice.
Am J Vet Res. 2014 Jul;75(7):619-25. doi: 10.2460/ajvr.75.7.619.
Foley et al. Evaluation of a Sustained-Release Formulation of Buprenorphine for Analgesia in Rats.
JAALAS, Vol 50, No 2 March 2011 Pages 198–204
Chum et al., Antinociceptive Effects of Sustained-Release Buprenorphine in a Model of Incisional Pain in Rats (Rattus norvegicus)
JAALAS, Vol 53, No 2, March 2014, Pages 193–197
Development of sustained release buprenorphine for use as an improved analgesic in toxicology studies: assessment of formulation pharmacokinetics.
Koetzner, L; Stokes, W; Lance, W; Wnorowski, G; South, N; Boulet, J
Scientific Poster 320; Abstract 502, Society of Toxicology Proceedings, 2012.
Short-acting and Long-acting Buprenorphine Therapeutic Drug Levels Following Single Subcutaneous Administration in Yucatan Miniswine.
Hanks B, Schlink S, Brown LD, Luna M, Liu YS, Liu J, Stricker-Krongrad A, Bouchard GF.
Scientific Poster and abstract, Proceedings: Association for Clinical and Translational Science (ACTS) 2013.
Pharmacokinetics of Sustained-Release and Transdermal Buprenorphine in Göttingen Minipigs (Sus scrofa domestica).
Thiede, AJ1; Garcia, KD; Stolarik, DF; Ma, J; Jenkins, GJ; Nunamaker, EA4
Journal of the American Association for Laboratory Animal Science, Volume 53, Number 6, November 2014, pp. 692-699(8)
Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).
Nunamaker EA1, Halliday LC, Moody DE, Fang WB, Lindeblad M, Fortman JD.
Journal of the American Association for Laboratory Animal Science, 2013 Jan;52(1):48-56.
Pharmacokinetics of 3 Formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).
Bauer C1, Frost P, Kirschner S. J
Journal of the American Association for Laboratory Animal Science, 2014 Sep;53(5):502-11.